“…To answer this question confidently, we first need to establish a catalogue of prescription medications with a 7-DHC elevating side effects [ 47 , 48 , 49 ], and try to avoid their simultaneous use [ 2 , 50 , 51 ], especially in patients with the DHCR7 +/- genotype [ 52 ] (who already have a baseline elevation of 7-DHC). However, based on the available data showing that concurrent use of 7-DHC elevating beta-blockers and psychotropic medications [ 53 , 54 ] can have adverse cardiac effects in patients [ 55 ], we suggest that clinical side effects could be related to heart muscle function [ 56 ]. Furthermore, the organ-specific side effects might depend on the exact combination of prescription polypharmacy, defined by the medications’ target organ to a large degree [ 55 , 57 , 58 , 59 ].…”